Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2012
10/03/2012CN102702209A Quaternary cationic quaternary ammnonium and preparation method thereof
10/03/2012CN102702208A Bromine-containing indole [3,2-b] carbazole derivative and preparation method thereof
10/03/2012CN102702207A Method for preparing imidazole isobenzazole compound
10/03/2012CN102702206A Method for extracting alexine
10/03/2012CN102702205A Preparation method of sitagliptin
10/03/2012CN102702147A Andrographolide analogue and application of andrographolide analogue to treatment
10/03/2012CN102702064A 2,4,6-phenylsubstituierte cyclische ketoenole
10/03/2012CN102702044A Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
10/03/2012CN102697183A Cigarette filter additive with harm reduction effect and preparation method and application thereof
10/03/2012CN102697182A Preparation method of filter nozzle additive for lowering ammonia in smoke of cigarette and application thereof
10/03/2012CN102030701B Fluoradene derivative and preparation method thereof
10/03/2012CN101945870B 5-anilinoimidazopyridines and methods of use
10/03/2012CN101842917B Use of halogenated phthalocyanines
10/03/2012CN101580535B Hcv protease inhibitors
10/03/2012CN101522681B Certain chemical entities, compositions and methods
10/03/2012CN101233135B Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV
10/02/2012US8278312 Imidazo 1,2-a pyrimidine derivatives for the treatment of diseases such as diabetes
10/02/2012US8278297 Protein kinase inhibitors
10/02/2012US8278295 Amino-heterocyclic compounds
10/02/2012CA2685597C Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use
10/02/2012CA2675651C Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk] [1] -benzazepin-2 [1h] -one and zilpaterol
09/2012
09/27/2012WO2012129381A1 Deuterated preladenant
09/27/2012WO2012129338A1 Azole compounds as pim inhibitors
09/27/2012WO2012129014A1 Piperidine carboxamide spirohydantoin cgrp receptor antagonists
09/27/2012WO2012129013A1 Piperidinone carboxamide spirohydantoin cgrp receptor antagonists
09/27/2012WO2012128868A1 Cytotoxic benzodiazepine derivatives
09/27/2012WO2012128165A1 Resin-transfer-moldable terminal-modified imide oligomer using 2-phenyl-4,4'-diaminodiphenyl ether and having excellent moldability, mixture thereof, varnish containing same, and cured resin thereof and fiber-reinforced cured resin thereof made by resin transfer molding and having excellent heat resistance
09/27/2012WO2012127506A1 Substituted fused tricyclic compounds, compositions and medicinal applications thereof
09/27/2012WO2012127212A1 Imidazo [1, 2 - b] pyridazine derivatives as cdpk1 inhibitors
09/27/2012WO2012126275A1 Spiro-containing dihydropyrazole compounds
09/27/2012WO2012126084A1 Hsp-90 binding compounds, compositions thereof, and their use iν the treatment and prevention of fungal infections
09/27/2012WO2012065963A3 Antiviral condensed heterocyclic compounds
09/27/2012US20120245508 Synthesis of chlorins and phorbines with enhanced red spectral features
09/27/2012US20120245349 Process for the production of a pemetrexed salt
09/27/2012US20120245171 Benzpyrazole derivatives as inhibitors of pi3 kinases
09/27/2012US20120245170 Pyrazolopyridine derivatives as anticancer agent
09/27/2012US20120245169 Certain chemical entities, compositions and methods
09/27/2012US20120245168 Composition, Synthesis, and Use of New Substituted Pyran and Pterin Compounds
09/27/2012US20120245162 Oxadiazole inhibitors of leukotriene production
09/27/2012US20120245158 Gamma secretase modulators
09/27/2012US20120245153 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
09/27/2012US20120245150 NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245149 NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245125 Pyridazine compounds, compositions and methods
09/27/2012US20120244172 Conjudates of Pyrrolo[1,4]Benzodiazepine Dimers As Anticancer Agents
09/27/2012US20120244171 Cytotoxic benzodiazepine derivatives
09/27/2012US20120241681 4H-Imidazo[1,2-a]imidazoles for Electronic Applications
09/27/2012CA2830882A1 Substituted fused tricyclic compounds, compositions and medicinal applications thereof
09/27/2012CA2830780A1 Azole compounds as pim inhibitors
09/27/2012CA2830348A1 Piperidinone carboxamide spirohydantoin cgrp receptor antagonists
09/27/2012CA2824864A1 Cytotoxic benzodiazepine derivatives
09/26/2012EP2502912A2 Modulators of ATP-binding cassette transporters
09/26/2012EP2501699A1 New macrocyclic derivatives of glycolurils, and methods of preparing and using the same
09/26/2012EP2501695A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
09/26/2012EP2501387A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
09/26/2012CN1914225B HCV NS-3 serine protease inhibitors
09/26/2012CN102696126A Organic electroluminescent element
09/26/2012CN102695709A Crystalline forms of substituted pyrazolopyrimidines
09/26/2012CN102690414A Soluble rosinyl polyimide, film and preparation method of film
09/26/2012CN102690289A Method for preparing glyphosate
09/26/2012CN102690273A Preparation method of sildenafil
09/26/2012CN102690272A Method for extracting isoborreverine
09/26/2012CN102690271A Preparation process for intermediate of Lamellarin H
09/26/2012CN102690270A Pyrimidine compound and purpose thereof
09/26/2012CN102690269A Trifluoro methyl substituted quinoline or quinoxaline compound and preparation method thereof, and pharmaceutical composition containing the compound and purpose thereof
09/26/2012CN102690268A Racemization method of eszopiclone
09/26/2012CN102688250A Synthesis and application of azo derivatives as inhibitor of RSK2
09/26/2012CN102127085B Use of pyrimido[5,4-g]pteridines as shading component in color filter colorant compositions
09/26/2012CN101781312B Method for synthesizing derivatives of quinoline or indole
09/26/2012CN101583365B Triazine derivatives and their therapeutical applications
09/26/2012CN101035790B (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
09/25/2012US8273895 NK1 antagonists
09/25/2012US8273879 Triazolo pyrimidine compounds
09/25/2012US8273765 Bicyclo-pyrazoles and pharmaceutical compositions comprising them
09/25/2012US8273762 Hexahydro-pyrrolo-isoquinoline compounds
09/25/2012US8273758 Substituted tricyclic derivatives
09/25/2012US8273756 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
09/25/2012US8273754 Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds
09/25/2012US8273753 Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
09/25/2012US8273752 Substituted imidazopyrimidines and triazolopyrimidines
09/25/2012US8273751 Organic compounds
09/25/2012US8273750 7,8-dihydro-[1H or 2H]-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one or 7,8,9-trihydro-[1H or 2H]-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one, substituted at the 1 or 2 position with C2-]alkyl, C3-9 cycloalkyl, heteroarylalkyl, or arylalkyl; phosphodiesterase 1 inhibitors; Parkinsons disease
09/25/2012US8273741 Imidazo-pyridazinyl compounds and uses thereof
09/25/2012US8273734 5HT2C receptor modulators
09/25/2012US8273269 Red colour filter composition
09/25/2012CA2593264C Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
09/20/2012WO2012125893A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
09/20/2012WO2012125887A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
09/20/2012WO2012125886A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
09/20/2012WO2012125746A1 Tricyclic gyrase inhibitors
09/20/2012WO2012125622A1 Substituted adipic acid amides and uses thereof
09/20/2012WO2012125603A1 Macrocyclic compounds as alk, fak and jak2 inhibitors
09/20/2012WO2012125598A1 Benzodioxane inhibitors of leukotriene production
09/20/2012WO2012125544A2 Necroptosis inhibitors and methods of use therefor
09/20/2012WO2012125518A1 Salt forms of 3 - cyclopropylcarbonyl - 3, 6 - diazabicyclo [3.1.1] heptane
09/20/2012WO2012124696A1 Guanidine compound
09/20/2012WO2012123848A1 Tetraazaperopyrene compounds and their use as n-type semiconductors
09/20/2012WO2012123522A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor
09/20/2012WO2012123470A1 Imidazo pyrazines
09/20/2012WO2012123298A1 Antiviral compounds
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 573